It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Writer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
U.K.’s variant trackers led the way. Now others are following.

World Feb 28, 2021

U.K.’s variant trackers led the way. Now others are following.

The COVID-19 Genomics U.K. Consortium has become a global model for analyzing genomes for signs that the coronavirus is gaining power to spread — or to kill.

Spread of variants sparks push for all-in-one COVID-19 vaccines

World / Science & Health Feb 14, 2021

Spread of variants sparks push for all-in-one COVID-19 vaccines

Dangerous coronavirus variants are carpeting the globe, pushing scientists in the U.K. and elsewhere to target multiple versions of the pathogen in a single shot.

Vaccine disparities raise alarm as coronavirus variants multiply

World / Science & Health Jan 19, 2021

Vaccine disparities raise alarm as coronavirus variants multiply

Global gaps in access to vaccines are raising concerns that the spread of the virus will breed more dangerous versions of the pathogen, weakening medical weapons.

Vaccines don’t mean we’ll see the last of COVID-19, experts warn

World / Science & Health Dec 21, 2020

Vaccines don’t mean we’ll see the last of COVID-19, experts warn

Even with the latest technologies, money and might behind the unprecedented global drive to knock out COVID-19, the disease is unlikely to be eliminated any time soon.

How the Moderna and Pfizer coronavirus vaccines stack up

World / Science & Health Nov 17, 2020

How the Moderna and Pfizer coronavirus vaccines stack up

The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.

Getting vaccine doubters to roll up their sleeves won’t be easy

World | FOCUS Oct 19, 2020

Getting vaccine doubters to roll up their sleeves won’t be easy

Fading trust in governments, political interference and the dash to create a shot in record time are sowing doubts.

Developing countries don’t want to wait for superpowers’ vaccines

World / Science & Health | FOCUS Aug 26, 2020

Developing countries don’t want to wait for superpowers’ vaccines

After COVID-19’s emergence in Buenos Aires led to a strict lockdown in March, Juliana Cassataro and her fellow vaccine researchers grew concerned. The U.S., Europe and China had already revved up their quests to obtain shots; how far back in line would Argentina have ...

When it comes to COVID-19 vaccines, rich nations are first in line

World / Science & Health Aug 2, 2020

When it comes to COVID-19 vaccines, rich nations are first in line

Wealthy countries have already locked up more than a billion doses of coronavirus vaccines, raising worries that the rest of the world will be at the back of the queue in the global effort to defeat the pathogen. Moves by the U.S. and U.K. to ...

How Trump's fix-it man became $1.2 million headache for Novartis

World / Politics | FOCUS May 17, 2018

How Trump's fix-it man became $1.2 million headache for Novartis

When Michael Cohen showed up at Novartis AG last year proposing to help the drugmaker navigate the Donald Trump administration, it sounded like a promising opportunity. Cohen had, after all, served as an attorney for Trump and had close ties to the new president. It ...

Takeda shares slide amid $50 billion takeover bid for Shire

Business / Corporate Mar 29, 2018

Takeda shares slide amid $50 billion takeover bid for Shire

Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever. The decline in early Tokyo ...

« 1 2 3 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

SUSTAINABLE JAPAN

Support our journalism

Staying informed during times of uncertainty is crucial, which is why The Japan Times is providing free access to select stories about the coronavirus pandemic. Please consider subscribing today and support our efforts to deliver the news that matters.
SUBSCRIBE NOW
The Japan Times circular logo

SPECIAL SUPPLEMENTS

Sponsored contents planned and edited by JT Media Enterprise Division.

広告出稿に関するおといあわせはこちらまで

Read more

SUPPLEMENTS BINDER

international-reports
  • Bridges by SMS
  • Global Insight
  • GMI Post
  • World Eye Reports
Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times